Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Medical Genetics

• Publication date

  2000-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1136/jmg.37.11.817PMID 11073534PMCID PMC1734482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus.

  2000cited by this paper
• A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I

  2000cited by this paper
• The GDNF family ligands and receptors - implications for neural development.

  2000cited by this paper
• Characterisation of the human GFRα-3locus and investigation of the gene in Hirschsprung disease

  2000cited by this paper
• Regulation of cell fate decision of undifferentiated spermatogonia by GDNF.

  2000cited by this paper
• Transforming Ability of MEN2A-RET Requires Activation of the Phosphatidylinositol 3-Kinase/AKT Signaling Pathway*

  2000cited by this paper
• Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells*

  2000cited by this paper
• Incidence of RET mutations in patients with Hirschsprung's disease.

  2000cited by this paper
• A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations.

  2000cited by this paper
• Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.

  2000cited by this paper
• In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin.

  2000cited by this paper
• Abrogation of Nerve Growth Factor-induced Terminal Differentiation by ret Oncogene Involves Perturbation of Nuclear Translocation of ERK*

  2000cited by this paper
• Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130Cas mediated by Ret kinase

  1999cited by this paper
• Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation

  1999cited by this paper
• A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma.

  1999cited by this paper
• Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma

  1999cited by this paper
• Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130[Cas] mediated by Ret kinase

  1999cited by this paper
• The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain.

  1999cited by this paper
• RET proto-oncogene in the development of human cancer.

  1999cited by this paper
• Co‐segregation of MEN2 and Hirschsprung's disease: The same mutation of RET with both gain and loss‐of‐function?

  1999cited by this paper
• Germline V804M Mutation in the RET Proto-oncogene in Two Apparently Sporadic Cases of MTC Presenting in the Seventh Decade of Life

  1999cited by this paper
• Investigation of germline GFRα-1 mutations in Hirschsprung disease

  1999cited by this paper
• The Role of Amino Acids Surrounding Tyrosine 1062 in Ret in Specific Binding of the Shc Phosphotyrosine-Binding Domain1.

  1999cited by this paper
• Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease.

  1999cited by this paper
• Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation.

  1999cited by this paper
• Two Germline Missense Mutations at Codons 804 and 806 of the RET Proto‐oncogene in the Same Allele in a Patient with Multiple Endocrine Neoplasia Type 2B without Codon 918 Mutation

  1999cited by this paper
• Specific polymorphisms in the RETproto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression

  1999cited by this paper
• Investigation of germline GFR alpha-1 mutations in Hirschsprung disease.

  1999cited by this paper
• Receptors of the Glial Cell Line-Derived Neurotrophic Factor Family of Neurotrophic Factors Signal Cell Survival through the Phosphatidylinositol 3-Kinase Pathway in Spinal Cord Motoneurons

  1999cited by this paper
• Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?

  1999cited by this paper
• A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.

  1999cited by this paper
• Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease.

  1999cited by this paper
• Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma.

  1998cited by this paper
• Low frequency of RET mutations in Hirschsprung disease in Sweden

  1998cited by this paper
• A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.

  1998cited by this paper
• Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines

  1998cited by this paper
• Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease.

  1998cited by this paper
• Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B)

  1998cited by this paper
• Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2

  1998cited by this paper
• A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto‐oncogene in two families affected by familial medullary thyroid carcinoma

  1998cited by this paper
• Protein Kinase B Activation and Lamellipodium Formation Are Independent Phosphoinositide 3-Kinase-Mediated Events Differentially Regulated by Endogenous Ras

  1998cited by this paper
• Grb2 binding to the different isoforms of Ret tyrosine kinase

  1998cited by this paper
• Human GFRA1: cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility.

  1998cited by this paper
• Duplication of 9 base pairs in the critical cysteine‐rich domain of the RET proto‐oncogene causes multiple endocrine neoplasia type 2A

  1998cited by this paper
• Investigation of the genes for RET and its ligand complex, GDNF/GFR alpha-I, in small cell lung carcinoma.

  1998cited by this paper
• Investigation of the genes for RET and its ligand complex, GDNF/GFRα‐1, in small cell lung carcinoma

  1998cited by this paper
• Expression of RET 3′ splicing variants during human kidney development

  1998cited by this paper
• Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.

  1998cited by this paper
• Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.

  1997cited by this paper
• The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype.

  1997cited by this paper
• A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A.

  1997cited by this paper
• Identification of Shc docking site on Ret tyrosine kinase

  1997cited by this paper
• Germline mutation of RET codon 883 in two cases of de novo MEN 2B

  1997cited by this paper
• The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck

  1997cited by this paper
• Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain

  1997cited by this paper
• A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma.

  1997cited by this paper
• Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations.

  1997cited by this paper
• Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.

  1997cited by this paper
• Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

  1997cited by this paper
• Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations

  1997cited by this paper
• Mutations of the RET proto‐oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease

  1997cited by this paper
• Expression of multiple endocrine neoplasia 2B RET in neuroblastoma cells alters cell adhesion in vitro, enhances metastatic behavior in vivo, and activates Jun kinase.

  1997cited by this paper
• Glial Cell Line-derived Neurotrophic Factor Induces Ret-mediated Lamellipodia Formation*

  1997cited by this paper
• RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2

  1997cited by this paper
• Mutation of RET codon 768 is associated with the FMTC phenotype

  1997cited by this paper
• RET proto-oncogene point mutations in sporadic neuroendocrine tumors.

  1996cited by this paper
• Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group.

  1996cited by this paper
• Expression of the cret proto-oncogene during mouse embryogenesis

  1996cited by this paper
• Characterization of ret oncogenic activation in MEN2 inherited cancer syndromes.

  1996cited by this paper
• Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts.

  1996cited by this paper
• De Novo Mutation of GDNF, Ligand for the RET/GDNFR-α Receptor Complex, in Hirschsprung Disease

  1996cited by this paper
• Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation.

  1996cited by this paper
• Oncogenic RET Receptors Display Different Autophosphorylation Sites and Substrate Binding Specificities (*)

  1996cited by this paper
• Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.

  1996cited by this paper
• Mutations of the ret protooncogene in German multiple endocrine neoplasia families: Relation between genotype and phenotype.

  1996cited by this paper
• Mechanism of ret dysfunction by Hirschsprung mutations affecting its extracellular domain.

  1996cited by this paper
• Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease

  1996cited by this paper
• The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

  1996cited by this paper
• No mutations found byRET mutation scanning in sporadic and hereditary neuroblastoma

  1996cited by this paper
• Statement of the American Society of Clinical Oncology : Genetic testing for cancer susceptibility. Commentaries

  1996cited by this paper
• GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF

  1996cited by this paper
• De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.

  1996cited by this paper
• GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.

  1996cited by this paper
• Glial Cell Line-derived Neurotrophic Factor Signals through the RET Receptor and Activates Mitogen-activated Protein Kinase*

  1996cited by this paper
• Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient

  1996cited by this paper
• Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto‐oncogene

  1996cited by this paper
• Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma.

  1996cited by this paper
• Molecular heterogeneity of RET loss of function in Hirschsprung's disease.

  1996cited by this paper
• Characterization of a multicomponent receptor for GDNF

  1996cited by this paper
• Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.

  1996cited by this paper
• A Mutation at Tyrosine 1062 in MEN2A-Ret and MEN2B-Ret Impairs Their Transforming Activity and Association with Shc Adaptor Proteins*

  1996cited by this paper
• The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma

  1996cited by this paper
• The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families

  1996cited by this paper
• Functional recovery in parkinsonian monkeys treated with GDNF

  1996cited by this paper
• Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.

  1995cited by this paper
• Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

  1995cited by this paper
• Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

  1995cited by this paper
• Tyrosines outside the Kinase Core and Dimerization Are Required for the Mitogenic Activity of RET/ptc2 (*)

  1995cited by this paper
• Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease.

  1995cited by this paper
• A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.

  1995cited by this paper

• Characterization and identification of RET gene variations in children with Hirschsprung disease

  2025cites this paper
• Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer

  2025cites this paper
• MEN2: surgical precision in the era of precision medicine

  2025cites this paper
• Approach to the Patient: Hereditary Medullary Thyroid Carcinoma.

  2025cites this paper
• Unlocking the Potential of Multigene Parallel Sequencing: A Concomitant Germline RET and BRCA1 Mutation in a Hereditary Medullary Thyroid Carcinoma

  2024cites this paper
• Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targeting in Thyroid Cancer

  2024cites this paper
• Targeting the RET tyrosine kinase in neuroblastoma: a review and application of a novel selective drug design strategy.

  2023cites this paper
• Research progress of neural invasion in pancreatic cancer.

  2023cites this paper
• Case Report of Rare Hereditary Endocrine Cancer Syndrome: Multiple Endocrine Neoplasia Type 2B

  2022cites this paper
• The Polycomb group gene rnf2 is essential for central and enteric neural system development in zebrafish

  2022cites this paper
• Genetic Analysis of Medullary Thyroid Cancer in Algiers, Algeria

  2022influential citation
• Increased RET Activity Coupled with a Reduction in the RET Gene Dosage Causes Intestinal Aganglionosis in Mice

  2021cites this paper
• Paraganglioma and Pheochromocytoma

  2021cites this paper
• RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer

  2021cites this paper
• Cystic ovarian teratoma as a novel tumor and growth hormone deficiency as new conditions presenting in Multiple Endocrine Neoplasia type 2B: Case reports and review of the literature.

  2021cites this paper
• Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents

  2021cites this paper
• Gastrointestinal Tract

  2020cites this paper
• The role of GDNF and its receptor GFRa1 in neuronal development and function

  2020cites this paper
• RET overactivation leads to concurrent Hirschsprung disease and intestinal ganglioneuromas.

  2020cites this paper
• Krankheiten des endokrinen Systems

  2020cites this paper
• Disorders of neural crest derivates in oncoradiological practice

  2019cites this paper
• A primer on the genetics of medullary thyroid cancer.

  2019cites this paper
• Craniocaudal Migration/Neurocristopathy

  2019cites this paper
• [Imaging of medullary thyroid carcinoma].

  2019cites this paper
• Genetics of diverse phenotypes in Hirschsprung disease - extension of aganglionosis, heredity and medullary thyroid carcinoma

  2019cites this paper
• Influencers on Thyroid Cancer Onset: Molecular Genetic Basis

  2019cites this paper
• Molecular Genetics and Diagnostics of Thyroid Cancer

  2019cites this paper
• Overview of Genetically Determined Diseases/Multiple Endocrine Neoplasia Syndromes Predisposing to Endocrine Tumors.

  2019cites this paper
• Commentary Pediatric Ethics Guidelines for Hereditary Medullary Thyroid Cancer

  2018cites this paper
• Chapter 7 – Cancer Syndromes That Present in Childhood

  2018cites this paper
• Drilling for Insight: Forecasting Phenotype from Genotype.

  2018cites this paper
• 2-6-2011 Pediatric Ethics Guidelines for Hereditary Medullary Thyroid Cancer

  2018cites this paper
• A comprehensive review on MEN2B.

  2017cites this paper
• Molecular Testing in Thyroid Cancer

  2017cites this paper
• Oncogenesis of Thyroid Cancer

  2017cites this paper
• A review of diagnostic approaches to medullary thyroid carcinoma

  2017cites this paper
• Tumors of the Diffuse Neuroendocrine and Gastroenteropancreatic System

  2017cites this paper
• Hirschsprung’s disease: clinical dysmorphology, genes, micro-RNAs, and future perspectives

  2017cites this paper
• Diseases of the Endocrine System

  2016cites this paper
• Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations.

  2016cites this paper
• PTH and Vitamin D.

  2016cites this paper
• Pediatric Medullary Thyroid Carcinoma

  2016cites this paper
• A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A

  2016cites this paper
• On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited

  2016cites this paper
• The Multiple Endocrine Neoplasia Syndromes

  2015cites this paper
• Questioning the pathogenic role of the pTyr791Phe mutation of the RET proto-oncogene: Insight from a case report.

  2015cites this paper
• Molecular analysis of the rearranged during transfection proto-oncogene in Moroccan patients with medullary thyroid carcinoma

  2015cites this paper
• Hirschsprung Disease Overview

  2015cites this paper
• RET RECEPTOR ACTIVATION TARGETS EXPRESSION OF THE PLEIOTROPIC CYTOKINE INTERLEUKIN-11

  2015cites this paper
• Use of Co processed excipients in Direct Compression Tablets - A Review

  2015cites this paper
• Proteomic Identification of DNA-PK Involvement within the RET Signaling Pathway

  2015cites this paper
• A ten‐year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relatives

  2014cites this paper
• Molecular approaches to thyroid cancer diagnosis.

  2014cites this paper
• Enigma Prevents Cbl-c-Mediated Ubiquitination and Degradation of RETMEN2A

  2014cites this paper
• Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.

  2014cites this paper
• Paragangliomas/Pheochromocytomas: Clinically Oriented Genetic Testing

  2014cites this paper
• Personalization of Targeted Therapy in Advanced Thyroid Cancer

  2014cites this paper
• Uptodate view on diagnostics and treatment of medullary thyroid cancer

  2013cites this paper
• Thyroid cancer and co-occurring RET mutations in Hirschsprung disease.

  2013cites this paper
• Screening of the RET Proto-oncogene in Families with Multiple Endocrine Neoplasia Type 2 in Algeria

  2013cites this paper
• Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors.

  2013cites this paper
• Proteome-wide discovery of mislocated proteins in cancer

  2013cites this paper
• Essential genes in thyroid cancers: focus on fascin

  2013cites this paper
• Caracterização do fenótipo e rastreamento gênico em famílias com neoplasia endócrina múltipla tipo 2A devido à nova dupla mutação germinativa C634Y/Y791F no proto-oncogene RET

  2013cites this paper
• Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma

  2013cites this paper
• RET codon 618 mutations in Saudi families with multiple endocrine neoplasia Type 2A and familial medullary thyroid carcinoma

  2013cites this paper
• New Perspectives on Diagnostics, Prognosis, and Therapy in Aggressive Endocrine Tumours

  2012cites this paper
• Epidemiology and prevention of head and neck cancer

  2012cites this paper
• Hereditary Medullary Thyroid Cancer: Age-Appropriate Thyroidectomy Improves Disease-Free Survival

  2012cites this paper
• Role of glial cell line-derived neurotrophic factor in perineural invasion of pancreatic cancer.

  2012cites this paper
• Review Article Inflammation in thyroid oncogenesis

  2012cites this paper
• Novel molecular targeted therapies for refractory thyroid cancer

  2012cites this paper
• Inflammation in thyroid oncogenesis.

  2012cites this paper
• Genetic and Clinical Features of Multiple Endocrine Neoplasia Types 1 and 2

  2012cites this paper
• Multiple endocrine neoplasias type 2B and RET proto-oncogene

  2012cites this paper
• Pediatric Ethics Guidelines for Hereditary Medullary Thyroid Cancer

  2011cites this paper
• Molecular Analysis of the RET Proto-Oncogene Key Exons in Patients with Medullary Thyroid Carcinoma: A Comprehensive Study of the Iranian Population

  2011cites this paper
• Multiple endocrine neoplasia type 2: An overview

  2011cites this paper
• Unusual case of multiple endocrine neoplasia type 2A syndrome without medullary thyroid carcinoma.

  2011cites this paper
• Evaluation of systemic targeting of RET oncogene-based MTC with tumor-selective peptide-tagged Ad vectors in clinical mouse models

  2011cites this paper
• Clinical utility gene card for: multiple endocrine neoplasia type 2

  2011cites this paper
• Aptamers: potential applications to pancreatic cancer therapy.

  2011cites this paper
• Management of medullary thyroid carcinoma and MEN2 syndromes in childhood

  2011cites this paper
• Functional and genetic studies in MEN2 and Hirschsprung disease

  2010cites this paper
• Recent Developments in the Molecular Biology of the Thyroid

  2010cites this paper
• Thyroid Cancer: Current Molecular Perspectives

  2010cites this paper
• Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro.

  2010cites this paper
• Future Directions in Endocrine Pathology

  2010cites this paper
• Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?

  2010cites this paper
• The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer

  2010cites this paper
• Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells and xenografts via apoptosis

  2010cites this paper
• Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma.

  2010cites this paper
• Genetics of Hirschsprung disease and anorectal malformations.

  2010cites this paper
• Multi-targeted approach in the treatment of thyroid cancer.

  2010cites this paper
• The Frequency of Selected Polymorphic Variants of the RET Gene in Patients with Medullary Thyroid Carcinoma and in the General Population of Central Poland

  2010cites this paper
• Thyroid cancer and inflammation.

  2010cites this paper
• Chapter 7 – Thyroid and Parathyroid Glands

  2009cites this paper
• Cell-specific aptamers for targeted therapies.

  2009cites this paper
• A novel mutation (D631del) of the RET gene was associated with MEN2A in a Chinese pedigree.

  2009cites this paper
• Glioblastoma multiforme y neoplasia endocrina múltiple tipo 2 A

  2009cites this paper